Shuttle Pharmaceuticals Holdings (SHPH) Other Non-Current Liabilities (2021 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Other Non-Current Liabilities of $23423.0 for Q1 2026, down 76.58% year-over-year from $100000.0 in Q1 2025, and down 76.5% quarter-over-quarter from $99687.0 in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Other Non-Current Liabilities history runs 5 years deep, the most recent figure standing at $23423.0 for Q1 2026.
- In Q1 2026, Other Non-Current Liabilities fell 76.58% year-over-year to $23423.0; the TTM figure through Mar 2026 stood at $23423.0 (down 76.58% YoY), while the FY2025 annual figure was $99687.0, up 294.32% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $23423.0, down from $99687.0 in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $1.4 million in Q1 2023, with the low at $10965.0 in Q2 2025.
- The 4-year median for Other Non-Current Liabilities is $214615.0 (2024), against an average of $354432.1.
- Peak annual rise in Other Non-Current Liabilities reached 474.92% in 2025, while the deepest fall reached 96.96% in 2025.
- Shuttle Pharmaceuticals Holdings' Other Non-Current Liabilities stood at $414512.0 in 2023, then plunged by 93.9% to $25281.0 in 2024, then soared by 294.32% to $99687.0 in 2025, then plunged by 76.5% to $23423.0 in 2026.
- Business Quant data shows SHPH's Other Non-Current Liabilities at $23423.0 in Q1 2026, $99687.0 in Q4 2025, and $426054.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Shuttle Pharmaceuticals Holdings | 1.93 Mn | 1.93 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23,423.00 |
| Dec 31, 2025 | 99,687.00 |
| Sep 30, 2025 | 426,054.00 |
| Jun 30, 2025 | 10,965.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 25,281.00 |
| Sep 30, 2024 | 74,107.00 |
| Jun 30, 2024 | 360,423.00 |
| Mar 31, 2024 | 214,615.00 |
| Dec 31, 2023 | 414,512.00 |
| Sep 30, 2023 | 512,825.00 |
| Jun 30, 2023 | 955,725.00 |
| Mar 31, 2023 | 1.39 Mn |
| Dec 31, 2021 | 334,955.00 |